Trial Profile
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary)
- Indications Astrocytoma; Glioma; Oligodendroglioma
- Focus Therapeutic Use
- 03 Aug 2020 Status changed from active, no longer recruiting to completed.
- 28 Dec 2018 Status changed from recruiting to active, no longer recruiting.
- 14 Jun 2018 Planned End Date changed from 1 Dec 2019 to 1 Mar 2021.